高血压患者规律使用对乙酰氨基酚对血压的影响:PATH-BP试验
PATH-BP是一项双盲安慰剂对照交叉试验,纳入110例高血压患者,比较每日4g对乙酰氨基酚与安慰剂对血压的影响。结果显示对乙酰氨基酚显著升高日间收缩压(安慰剂校正后4.7 mmHg)和舒张压(1.6 mmHg),提示高血压患者规律使用对乙酰氨基酚可能增加心血管风险。
要点
- 高血压患者每日4g对乙酰氨基酚使日间收缩压较安慰剂升高4.7 mmHg。
- 日间舒张压亦较安慰剂升高1.6 mmHg,24小时动态和诊室血压结果相似。
- 高血压患者规律使用对乙酰氨基酚需权衡血压升高带来的心血管风险。
核心结论
- 高血压患者每日规律服用4g对乙酰氨基酚,与安慰剂相比,日间收缩压平均升高约5 mmHg,提示可能增加心血管风险。
研究设计与样本
- 双盲、安慰剂对照、交叉试验,110例高血压患者随机接受对乙酰氨基酚1g每日4次或匹配安慰剂治疗2周,洗脱2周后交叉。
- 研究在治疗期开始和结束时测量24小时动态血压,主要终点为日间平均收缩压从基线至治疗结束的变化在两组间的比较。
主要发现
- 安慰剂校正后日间收缩压升高4.7 mmHg(95%CI 2.9-6.6);日间舒张压升高1.6 mmHg(95%CI 0.5-2.7;P=0.005)。
- 24小时动态血压和诊室血压观察到类似结果。
关键数值与推荐
- 对乙酰氨基酚用法为1g每日4次(每日总剂量4g),连续2周。
- 主要终点为日间平均收缩压变化,组间差异P<0.0001。
临床怎么用
- 高血压患者需长期规律使用对乙酰氨基酚止痛时,应监测血压并评估心血管风险。
- 临床处方对乙酰氨基酚时应考虑其可能升高血压,尤其对于血压控制不佳的高血压患者。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acetaminophen is widely used as first-line therapy for chronic pain because of its perceived safety and the assumption that, unlike nonsteroidal anti-inflammatory drugs, it has little or no effect on blood pressure (BP). Although observational studies suggest that acetaminophen may increase BP, clinical trials are lacking. We, therefore, studied the effects of regular acetaminophen dosing on BP in individuals with hypertension. METHODS: In this double-blind, placebo-controlled, crossover study, 110 individuals were randomized to receive 1 g acetaminophen 4× daily or matched placebo for 2 weeks followed by a 2-week washout period before crossing over to the alternate treatment. At the beginning and end of each treatment period, 24-hour ambulatory BPs were measured. The primary outcome was a comparison of the change in mean daytime systolic BP from baseline to end of treatment between the placebo and acetaminophen arms. RESULTS: One-hundred three patients completed both arms of the study. Regular acetaminophen, compared with placebo, resulted in a significant increase in mean daytime systolic BP (132.8±10.5 to 136.5±10.1 mm Hg [acetaminophen] vs 133.9±10.3 to 132.5±9.9 mm Hg [placebo]; P<0.0001) with a placebo-corrected increase of 4.7 mm Hg (95% CI, 2.9-6.6) and mean daytime diastolic BP (81.2±8.0 to 82.1±7.8 mm Hg [acetaminophen] vs 81.7±7.9 to 80.9±7.8 mm Hg [placebo]; P=0.005) with a placebo-corrected increase of 1.6 mm Hg (95% CI, 0.5-2.7). Similar findings were seen for 24-hour ambulatory and clinic BPs. CONCLUSIONS: Regular daily intake of 4 g acetaminophen increases systolic BP in individuals with hypertension by ≈5 mm Hg when compared with placebo; this increases cardiovascular risk and calls into question the safety of regular acetaminophen use in this situation. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01997112. URL: https://www.clinicaltrialsregister.eu; Unique identifier: 2013-003204-40.
引用
- MacIntyre IM, Turtle EJ, Farrah TE, et al. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 2022. PMID: 35130054. doi:10.1161/CIRCULATIONAHA.121.056015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。